Molecular Immunology 52 (2012) 125–132
Contents lists available at SciVerse ScienceDirect
Molecular Immunology
jo u rn al hom epa ge: www.elsevier.com/locate/molimm
Inhibition of the transcription factor c-Jun by the MAPK family, and not the
NF-B pathway, suggests that peanut extract has anti-inflammatory properties
Úrsula Catalán
a
, Sara Fernández-Castillejo
a
, Neus Anglès
b
, Jose Ramón Morelló
b
, Martí Yebras
c
,
Rosa Solà
a,∗
a
Unitat de Recerca en Lípids i Arteriosclerosi, CIBERDEM, Hospital Universitari Sant Joan, IISPV, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus,
Tarragona, Spain
b
La Morella Nuts S.A., 43206 Castellvell del Camp, Tarragona, Spain
c
Serveis Científics i Tècnics, Universitat Rovira i Virgili, Spain
a r t i c l e i n f o
Article history:
Received 22 December 2011
Received in revised form 8 May 2012
Accepted 9 May 2012
Available online 4 June 2012
Keywords:
Lipopolysaccharide
THP-1
NF-B
Tumor necrosis factor-
Tumor necrosis factor- converting enzyme
a b s t r a c t
Background: Tumor necrosis factor- (TNF-) is involved in inflammatory responses in atherosclerosis.
We propose an in vitro cellular assay to evaluate the anti-inflammatory mechanisms of potential modifiers
such as food extracts. In the current model we assessed an anti-inflammatory effect of polyphenol-rich
peanut extract in lipopolysaccharide (LPS)-induced THP-1 monocytes.
Methods: THP-1 monocytes were incubated with peanut extract (5, 25, 50 and 100 g/mL) consisting of
39% flavonols, 37% flavanols and 24% phenolic acid (or BAY 11-7082 (5 M) as experiment control) for 1 h
and then stimulated with LPS (500 ng/mL) for 4 h. Cytotoxicity was measured as lactate dehydrogenase
(LDH) activity release. NF-B and MAPK family were determined by TransAm kit while TNF- mRNA
levels and its mRNA stability by RT-PCR. Intra- and extracellular TNF- protein was measured by ELISA,
and TNF- converting enzyme (TACE) activity by a fluorimetric assay.
Results: Peanut extract inhibited the maximal LPS-induced extracellular TNF- protein secretion by 18%,
29% and 47% at 25, 50 and 100 g/mL, respectively (P < 0.05). LPS stimulation revealed that 85% of TNF-
was released extracellularly while 15% remained intracellular. Peanut extract did not modify NF-B
but, instead, reduced c-Jun transcription factor activity (P < 0.05), decreased TNF- mRNA (albeit non-
significantly) and had no effect on mRNA stability and TACE activity.
Conclusion: Polyphenol-rich peanut extract reduces extracellular TNF- protein by inhibiting c-Jun
transcription factor from MAPK family, suggesting an anti-inflammatory effect. The proposed THP-1
monocyte model could be used to assess food extract impact (site and size effects) on the inflammation
pathway.
© 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Atherosclerosis is a complex inflammatory process involved
in cardiovascular disease (CVD), the principal cause of morbid-
ity and mortality in industrialized countries (Gerszten et al.,
2011). Inflammation is characterized by the presence of mono-
cytes/macrophages and T lymphocytes in the atheroma plaque
(Ross, 1999). Monocytes promote atherosclerosis via production
of various key mediators such as tumor necrosis factor- (TNF-).
TNF- is commonly found in atherosclerotic lesions contributing to
∗
Corresponding author at: Unitat de Recerca en Lípids i Arteriosclerosi, Hospital
Universitari Sant Joan, IISPV, Facultat de Medicina i Ciències de la Salut, Universitat
Rovira i Virgili, Sant Llorenc ¸ , 21, 43201 Reus, Tarragona, Spain.
Tel.: +34 977 75 93 69; fax: +34 977 75 93 22; mobile: +34 609 906 991.
E-mail address: rosa.sola@urv.cat (R. Solà).
the inflammatory process (Katsume et al., 2011). Concentrations of
TNF- are increased in patients with increased risk of atheroscle-
rosis (Devaraj et al., 2002).
The mechanisms underlying the first part of the pro-
inflammatory lipopolysaccharide (LPS)-induced TNF- signaling
pathway have been well described (Gee et al., 2002). The exposure
of cells to LPS, which is a major component of the outer membrane
of Gram-negative bacteria, triggers the binding of LPS to the LPS
bearing protein (LBP) and is transferred to the CD14 at the cell
surface. LPS then interacts with the signaling toll-like receptor 4
(TLR4) and the accessory protein MD-2. LPS stimulates the acti-
vation of various mitogen-activated protein kinase (MAPK) family
pathways, including the extracellular signal-regulated kinase (ERK)
1 and 2, c-Jun N-terminal kinase (JNK), and p38 pathways. These
pathways directly or indirectly phosphorylate and activate vari-
ous transcription factors including Elk-1, c-Jun, c-Fos, ATF-1, ATF-2,
SRF, and CREB. In addition, LPS activates the IKK pathway which
0161-5890/$ – see front matter © 2012 Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.molimm.2012.05.007